BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14647461)

  • 1. MLL-AF9 oncogene expression affects cell growth but not terminal differentiation and is downregulated during monocyte-macrophage maturation in AML-M5 THP-1 cells.
    Pession A; Martino V; Tonelli R; Beltramini C; Locatelli F; Biserni G; Franzoni M; Freccero F; Montemurro L; Pattacini L; Paolucci G
    Oncogene; 2003 Nov; 22(54):8671-6. PubMed ID: 14647461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of MLL-AF9, MLL and MYC expression is not obligatory for monocyte-macrophage maturation in AML-M5 cell lines carrying t(9;11)(p22;q23).
    Martino V; Tonelli R; Montemurro L; Franzoni M; Marino F; Fazzina R; Pession A
    Oncol Rep; 2006 Jan; 15(1):207-11. PubMed ID: 16328057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of HOXA4, HOXA7, HOXA10, HOXA11 and MEIS1 during monocyte-macrophage differentiation in THP-1 cells.
    Martino V; Bianchera A; Reia L; Bussolati O; Fazzina R; Marino F; Montemurro L; Tonelli R; Pession A; Gazzola GC; Sala R
    Mol Med Rep; 2009; 2(2):241-4. PubMed ID: 21475819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of MLL-AF9 fusion gene silence of acute monocytic leukemia cell line THP-1 on cyclin-dependent kinase inhibitor p27 expression].
    Li L; Liu LB; Wang L; Zou P
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jun; 29(6):375-8. PubMed ID: 19031738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.
    Krivtsov AV; Twomey D; Feng Z; Stubbs MC; Wang Y; Faber J; Levine JE; Wang J; Hahn WC; Gilliland DG; Golub TR; Armstrong SA
    Nature; 2006 Aug; 442(7104):818-22. PubMed ID: 16862118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rac1 signaling protects monocytic AML cells expressing the MLL-AF9 oncogene from caspase-mediated apoptotic death.
    Hinterleitner C; Huelsenbeck J; Henninger C; Wartlick F; Schorr A; Kaina B; Fritz G
    Apoptosis; 2013 Aug; 18(8):963-79. PubMed ID: 23624644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of an interphase fluorescence in situ hybridization approach for the detection of MLL gene rearrangements and of the MLL/AF9 fusion in acute myeloid leukemia.
    Cavazzini F; Bardi A; Tammiso E; Ciccone M; Russo-Rossi A; Divona D; Lo Coco F; Hernandez JM; Wlodarska I; Hagemeijer A; Castoldi G; Cuneo A
    Haematologica; 2006 Mar; 91(3):381-5. PubMed ID: 16503549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel AF9 breakpoint in MLL-AF9-positive acute monoblastic leukemia.
    Alonso CN; Longo PL; Gallego MS; Medina A; Felice MS
    Pediatr Blood Cancer; 2008 Apr; 50(4):869-71. PubMed ID: 18000862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment?
    Muntean AG; Hess JL
    Cancer Cell; 2008 Jun; 13(6):465-7. PubMed ID: 18538728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted down-regulation of MLL-AF9 with antisense oligodeoxyribonucleotide reduces the expression of the HOXA7 and -A10 genes and induces apoptosis in a human leukemia cell line, THP-1.
    Kawagoe H; Kawagoe R; Sano K
    Leukemia; 2001 Nov; 15(11):1743-9. PubMed ID: 11681416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of down-regulating mll-af9 gene expression on proliferation of acute monocytic leukemia cell line THP-1].
    Li L; Zhang AH; Liu LB; Bi L; Wang L; Zhao YJ; Zou P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):254-7. PubMed ID: 18426643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a MLL-AF9-specific stem cell model of acute monocytic leukemia.
    Chiew MY; Boo NY; Voon K; Cheong SK; Leong PP
    Leuk Lymphoma; 2017 Jan; 58(1):162-170. PubMed ID: 27185517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation.
    Schreiner S; Birke M; García-Cuéllar MP; Zilles O; Greil J; Slany RK
    Cancer Res; 2001 Sep; 61(17):6480-6. PubMed ID: 11522644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multistep pathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression.
    Yamaguchi H; Hanawa H; Uchida N; Inamai M; Sawaguchi K; Mitamura Y; Shimada T; Dan K; Inokuchi K
    Exp Hematol; 2009 Jun; 37(6):701-14. PubMed ID: 19463771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of HOXA9 activity by predominant expression of DACH1 against C/EBPα and GATA-1 in myeloid leukemia with MLL-AF9.
    Lee JW; Kim HS; Hwang J; Kim YH; Lim GY; Sohn WJ; Yoon SR; Kim JY; Park TS; Oh SH; Park KM; Choi SU; Ryoo ZY; Lee S
    Biochem Biophys Res Commun; 2012 Sep; 426(3):299-305. PubMed ID: 22902925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
    Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
    Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible MLL-AF9 Expression Drives an AML Program during Human Pluripotent Stem Cell-Derived Hematopoietic Differentiation.
    Heuts BMH; Arza-Apalategi S; Alkema SG; Tijchon E; Jussen L; Bergevoet SM; van der Reijden BA; Martens JHA
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mixed lineage leukemia fusion partner AF9 binds specific isoforms of the BCL-6 corepressor.
    Srinivasan RS; de Erkenez AC; Hemenway CS
    Oncogene; 2003 May; 22(22):3395-406. PubMed ID: 12776190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oncoprotein MLL-ENL disturbs hematopoietic lineage determination and transforms a biphenotypic lymphoid/myeloid cell.
    Zeisig BB; García-Cuéllar MP; Winkler TH; Slany RK
    Oncogene; 2003 Mar; 22(11):1629-37. PubMed ID: 12642866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of the two reciprocal t(4;11) fusion proteins MLL.AF4 and AF4.MLL confer resistance to apoptosis, cell cycling capacity and growth transformation.
    Gaussmann A; Wenger T; Eberle I; Bursen A; Bracharz S; Herr I; Dingermann T; Marschalek R
    Oncogene; 2007 May; 26(23):3352-63. PubMed ID: 17130830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.